
Clinical development teams still monitor trial data and safety signals through periodic reports, so a data integrity issue or an enrollment problem can go unnoticed for weeks. A trial's supply chain runs on separate systems from the data describing how the trial is going.
AI keeps the trial visible as it runs. Predictive models flag data integrity issues and supply risk as new records arrive, not at the next scheduled review. Generative AI drafts the summaries a trial team reads every week. Agents keep monitoring running between reports, so a signal doesn't wait on the next one. Your team sees the trial as it runs, not as it was last reported, on infrastructure you control.